| Announce Date | 08/11/2025 |
| EPS Normalized Actual | $-1 (Miss by $-0.22) |
| EPS GAAP Actual | $-1 (Miss by $-0.22) |
| Revenue Actual | $0.025691B |
| Revenue Surprise | Beat by $25.691M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $-4.16 |
| EPS GAAP Estimate | $-4.16 |
| Revenue Estimate | $0.0480786B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | -4.51 | -0.85 | -6.41056 | -3.47677 | 1 |
| Dec 2028 | -0.27 | -14.22 | -0.37289 | -0.19777 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -1 | -0.74125 | 0.025691B | 8.49% | -21.3M |
| FQ1 2025 (Mar 2025) | -1.03 | -1.03 | 0.024066B | -16.37% | 24.07M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 0.026837B | -212.26% | 26.84M |
| FQ3 2024 (Sep 2024) | -3.08 | -3.08 | 0.025112B | 3.18% | 25.11M |
| FQ2 2024 (Jun 2024) | -2.52 | -2.52 | 0.023509B | -7.6% | 23.51M |
| FQ1 2024 (Mar 2024) | -3.04 | -3.04 | 0.028005B | 18.22% | 28.01M |
| FQ4 2023 (Dec 2023) | -0.12 | -0.12 | 0.083801B | 10.2% | 83.8M |
| FQ3 2023 (Sep 2023) | -0.16 | -0.16 | 0.024314B | 6.34% | 24.31M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
-4.16
Consensus Revenue Estimates
0.0480786B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | -0.6143 | -- | -0.66131 | -0.58925 | 1 |
| FQ3 2027 (Sep 2027) | -0.6251 | -- | -0.67294 | -0.59961 | 1 |
| FQ2 2027 (Jun 2027) | -0.6389 | -- | -0.68779 | -0.61284 | 1 |
| FQ1 2027 (Mar 2027) | -0.6304 | -- | -0.67864 | -0.60469 | 1 |
| FQ4 2026 (Oct 2026) | -2.0164 | -- | -5.1692 | -0.67632 | 0 |
| FQ3 2026 (Jul 2026) | -2.1978 | -- | -5.63423 | -0.73716 | 0 |
| FQ2 2026 (Jun 2026) | -2.1978 | 54.5 | -4.01825 | -1.0731 | 1 |
| FQ1 2026 (Mar 2026) | -2.3957 | 57.01 | -4.38007 | -1.16973 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.03B | -- | 0.03B | 0.03B | 1 |
| FQ3 2027 (Sep 2027) | 0.03B | -- | 0.03B | 0.04B | 1 |
| FQ2 2027 (Jun 2027) | 0.03B | -- | 0.03B | 0.03B | 1 |
| FQ1 2027 (Mar 2027) | 0.03B | -- | 0.03B | 0.03B | 1 |
| FQ4 2026 (Oct 2026) | 0.09B | -- | 0.05B | 0.2B | 2 |
| FQ3 2026 (Jul 2026) | 0.09B | -- | 0.04B | 0.19B | 2 |
| FQ2 2026 (Jun 2026) | 0.09B | 70.38 | 0.05B | 0.14B | 2 |
| FQ1 2026 (Mar 2026) | 0.08B | 70.25 | 0.05B | 0.13B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
7
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.25875 | -1 | -0.74125 | 74.13% |
| FQ1 2025 (Mar 2025) | -1.03 | -1.03 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | -3.08 | -3.08 | 100% | |
| FQ2 2024 (Jun 2024) | -2.52 | -2.52 | 100% | |
| FQ1 2024 (Mar 2024) | -3.04 | -3.04 | 100% | |
| FQ4 2023 (Dec 2023) | -0.12 | -0.12 | 100% | |
| FQ3 2023 (Sep 2023) | -0.16 | -0.16 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0.05B | $0.03B | $-21.3M | -82.92% |
| FQ1 2025 (Mar 2025) | $0B | $0.02B | $24.07M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.03B | $26.84M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.03B | $25.11M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.02B | $23.51M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.03B | $28.01M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.08B | $83.8M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $0.02B | $24.31M | 100% |